Call for Papers! Cas12-mediated Genome Editing in Plants . Ca. 01. Time Schedule . Submission deadline: Sunday, 30th November, 2025. Expected acceptance deadline: ...

Eric Lucera, Editas Management, Editas: We are very fortunate to have the foundational Cas9, Cas12 license from Harvard MIT Broad. It’s a traditional university royalty rate that we think that ...

One is by out licensing the Cas9, Cas12 IP portfolio as we’ve done in the past with Vertex and then subsequently monetize that with DRI. The second way that we can do that is you’ve seen the ...

7,8 Cas12 and Cas13, relatives of Cas9, are particularly adept at this task. When these enzymes locate their target sequence in a sample—be it viral RNA or bacterial DNA—they trigger a ...

Advancements in cellular therapies offer new avenues for hope. Gene editing technologies like CRISPR-Cas9/Cas12 are being explored to correct the genetic mutations that cause thalassemia and sickle ...

We really have three ways that we could bring in capital aside from the traditional ranges. One is by out licensing the Cas9, Cas12 IP portfolio as we’ve done in the past with Vertex and then ...

New CRISPR systems got discovered, like Cas12, CAs12a, but also Cas13, Cas 5, Cas8, Csx10, etc… For now, most of the research efforts for human medicine are concentrated on CAs9 and CAs12. If you are ...

Technology Networks caught up with Professor Mazhar Adli to learn more about his research on the characterization of ...